First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study

  1. Di Leo, A.
  2. Jerusalem, G.
  3. Torres, R.
  4. Verhoeven, D.
  5. Pendergrass, K.
  6. Malorni, L.
  7. Lichfield, J.
  8. Martin, M.
Revue:
Breast

ISSN: 1532-3080,  0960-9776

Année de publication: 2018

Volumen: 38

Pages: 144-149

Type: Article

DOI: 10.1016/J.BREAST.2017.12.016 GOOGLE SCHOLAR
La source de données: Scopus